Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
acetaminophen-HYDROcodone
acetaminophen-HYDROcodone
- Formulary Narcotic - Oral Formulary
- Formulary Narcotic Liquids Formulary
- Non-formulary
- Therapeutic Interchange
Last updated: Aug. 23, 2017
- Black Box Warning: Hepatotoxicity
- Black Box Warning: Extended release: Abuse; Respiratory Depression; Accidental Ingestion; Withdrawal; Interactions
HYDROcodone/acetaminophen tablet products containing greater than 325 mg of acetaminophen are being phased out by the FDA. All HYDROcodone/acetaminophen tablet products should be interchanged to the equivalent NORCO product (see Narcotic-Oral Formulary).
LORTAB liquid (7.5 mg-500 mg/15 mL) is being phased out by the FDA. HYDROcodone-acetaminophen oral liquids should all be interchanged over to the new formulary HYDROcodone-acetaminophen liquid product (7.5 mg-325 mg/15 mL) at the same HYDROcodone dose. Reviewed: March 26, 2013
Reviewed: April 24, 2012 (LORTAB to NORCO interchange)
ZAMICET is classified as NON-FORMULARY, NOT-STOCKED OR ORDERED. Interchange to an equivalent dose (HYDROcodone component) of the formulary product (HYDROcodone 7.5 mg - acetaminophen 325 mg/15 mL). If patient is receiving too much acetaminophen, contact the prescriber to switch to a narcotic liquid and acetaminophen liquid administed separately. Reviewed: April 27, 2010 and March 26, 2013.